Intended for healthcare professionals


The balance of available evidence supports its use

BMJ 1995; 310 doi: (Published 15 April 1995) Cite this as: BMJ 1995;310:1005
  1. Simon P Harding
  1. Consultant ophthalmic surgeon Royal Liverpool University Hospital, Liverpool L7 8XP

    EDITOR,—J I McGill and J E White's paper adds further to the debate on the efficacy of oral acyclovir in herpes zoster ophthalmicus.1 It reports the long term follow up of a small sample of patients with ophthalmic complications from a study of 205 patients with herpes zoster in any dermatome.2 Pain and ocular complications were significantly less frequent at six months and five years. …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription